Skip to main content

Table 1 Summary of studies contributing to a) the circulating cortisol GWAS (CORNET), b) the maternal effects on pregnancy GWAS (EGG) and c) the observational pregnancy circulating cortisol (EFSOCH)

From: Maternal plasma cortisol’s effect on offspring birth weight: a Mendelian Randomisation study

a)

Study

Country

N

Age, years (SD)

Cortisol, nmol/l (SD)

Sampling time

ORCADES

UK

1974

53.5 (15.7)

765 (315)

0830-1030

CROATIA-Korcula

Croatia

898

56.2 (13.9)

698 (207)

0800-0900

CROATIA-Split

Croatia

496

45.0 (14.7)

979 (404)

0730-0900

CROATIA-Vis

Croatia

892

56.4 (15.5)

622 (230)

0730-0900

Rotterdam Study

Netherlands

6497

63.3 (9.6)

359 (115)

0800-1100

HBCS1934-44

Finland

451

60.61 (2.80)

393 (120)

0750-1055

NFBC1966

Finland

1324

31.1 (0.3)

380 (160)

0800-1100

ALSPAC

UK

1567

15.43 (0.26)

486 (174)

0800-1057

PIVUS

Sweden

919

70.2 (0.17)

386 (125)

0800-1000

PREVEND

Netherlands

1151

49.4 (13.0)

442 (201)

0800-1100

ET2DS

UK

1048

67.9 (4.2)

731 (190)

0800-0830

Raine Study

Australia

860

17.1 (0.29)

614 (235)

Awakening (before 1000)

MrOS Sweden

Sweden

969

75.3 (3.2)

487 (133)

0700-1000

VIKING

UK

2073

49.9 (15.2)

292 (170)

0800-1030

SHIP

Germany

910

49.8 (13.8)

*

Before 1300

TwinsUK

UK

5654

53.3 (13.8)

*

0800-1200

KORA

Germany

1651

60.92 (8.7)

*

NA

b)

Study

Country

N

Age, years (SD)

Birthweight, g (SD)

Gestational age, weeks (IQR)

UK Biobank

UK

190,406

25.3 (4.5)

3227 (477)

NA

B58C-WTCCC

UK

858

26.2 (5.2)

3325 (483)

40 (40–41)

B58C-T1DGC

UK

836

26.1 (5.4)

3379 (469)

40 (40–41)

DNBC-GOYA

Denmark

1805

29.2 (4.2)

3643 (495)

40 (39–41)

DNBC-PTB-CONTROL

Denmark

1656

29.9 (4.2)

3595 (497)

40 (39–40)

MoBa-2008

Norway

650

28.5 (3.3)

3679 (430)

40 (0.9)

NFBC1966

Finland

2035

26.5 (3.7)

3525 (461)

40 (2)

NTR

Netherlands

707

27.1 (3.7)

3469 (529)

40 (38–42)

QIMR

Australia

892

24.5 (4.0)

3344 (532)

NA

TWINSUK

UK

1603

NA

NA

NA

ALSPAC

UK

6,686

28.0 (5.0)

3468 (475)

40 (40–41)

HAPO

USA

1280

31.5 (5.3)

3557 (517)

40 (1.7)

EFSOCH

UK

855

30.5 (5.9)

3506 (472)

40 (37–43)

c)

Study

Country

N

Age, years (SD)

Cortisol, nmol/l (SD)

Sampling time

EFSOCH

UK

892

30.4 (5.3)

1010 (234)

0900 (within 60 minutes)

  1. aApart from EFSOCH [13] circulating cortisol (in pregnancy), the data comes from Crawford et al 2021 [11] and Warrington et al 2019 [12]
  2. bThis table only shows the studies that contributed maternal genotype and offspring birthweight data (n = 210,267) to the final WLM-adjusted GWAS of offspring birthweight (n = 406,063). More information regarding offspring genotype and own birthweight data can be found in Warrington et al. 2019
  3. cORCADES Orkney Complex Disease Study, HBCS1934-44 Helsinki Birth Cohort Study 1934-1944, NFBC1966 the Northern Finland 1966 Birth Cohort, ALSPAC Avon Longitudinal Study of Parents and Children; PIVUS Prospective Investigation of the Vasculature in Uppsala Seniors, PREVEND Prevention of Renal and Vascular End-stage Disease, ET2D2 Edinburgh Type 2 Diabetes Study, B58C-T1DGC British 1958 Birth Cohort – Type 1 Diabetes Genetics Consortium, MrOS Sweden Osteoporotic Fractures in Men-Sweden, KORA Cooperative Health Research in the Augsburg Region, SHIP Study of Health in Pomerania, VIKING Viking Health Study-Shetland, B58C-WTCCC British 1958 Birth Cohort – Wellcome Trust Case Control Consortium, DNBC-GOYA Danish National Birth Cohort – Genetics of Overweight Young Adults, DNBC-PTB-CONTROL Danish National Birth Cohort – Preterm Birth-Control Mothers, MoBa-2008 the Norwegian Mother and Baby Cohort, 2008, NTR Netherlands Twin Registry, QIMR Queensland Institute of Medical Research, HAPO Hyperglycaemia and Adverse Pregnancy Outcome Study, NA Not applicable;